Close Menu

NEW YORK (GenomeWeb) – Based on a new study, a team of Swiss researchers has made a case for expanding noninvasive prenatal testing beyond the three common trisomies — T21, T18, and T13 — and sex-chromosome anomalies to which many current NIPT assays limit themselves.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.